An evidence-based look at testosterone cypionate for muscle preservation in men with hypogonadism, covering dosing tradeoffs, resistance training, nutrition, and monitoring, with explicit notes on what is established versus what still needs verification.
A clinician-level guide to safely resuming testosterone cypionate injections after acute illness, covering timing, dose adjustments, lab monitoring, and the evidence behind restart decisions.
Evidence-based guide to holding testosterone cypionate before surgery: timing, thromboembolic risk, anesthesia interactions, lab monitoring, and restart protocols.
A clinician-level review of how testosterone cypionate affects kidney function in men with hypogonadism, covering mechanisms, trial data, risk stratification, and practical monitoring guidance.
A clinical guide to how seasons, light exposure, vitamin D status, and temperature affect testosterone cypionate therapy, with dosing adjustments, monitoring intervals, and primary-literature citations prepared by the HealthRX.com Editorial Team.
A deep dive into how genetic variants in AR, CYP19A1, SHBG, and CYP3A4 shape testosterone enanthate pharmacokinetics, efficacy, and side-effect risk, with dosing implications for clinical practice.
Testosterone enanthate causes only mild, transient enzyme rises, unlike oral alkylated androgens linked to real liver injury. See what the data shows.
A clinical deep-dive into testosterone enanthate microdosing protocols, covering dosing rationale, pharmacokinetics, the T-Trials data, and what board-certified physicians actually prescribe for male hypogonadism.
AUA guideline data on exogenous testosterone and spermatogenesis suppression, with HPG axis recovery timelines from 3 to 24+ months after stopping.
A clinician-level guide to how season, latitude, vitamin D status, and circadian shifts affect testosterone enanthate dosing, injection timing, and monitoring throughout the year.
GLP-1 receptor agonists have been in clinical use since 2005. This evidence-based review covers the full safety record, major trials, FDA warnings, and what patients starting these medications should know.
GLP-1 receptor agonists slow gastric emptying, which can reduce or delay the absorption of oral medications taken at the same time. Learn which drugs are most affected, what the clinical data show, and how to time your medications safely.
Levothyroxine restores thyroid hormone levels in hypothyroidism, which can reverse the weight gain caused by a slow metabolism. But for people with normal thyroid function, it does not produce meaningful fat loss and carries real risks. Read the full clinical picture.
Learn the clinical signs, lab markers, and evidence-based strategies to identify a slowing metabolism, including thyroid function, hormonal changes, and actionable next steps.
A guide to absolute contraindications, relative cautions, and high-risk populations for GLP-1 receptor agonist therapy, including semaglutide and tirzepatide.
Estrogen drops during menopause shrink hair follicles and shorten the growth cycle, causing visible thinning. This clinical guide covers diagnosis, proven treatments, and realistic expectations so you can act with a clear plan.
A guide identifying contraindications, cautions, and high-risk populations for GLP-1 receptor agonist therapy, including semaglutide and tirzepatide.
Does vaginal estradiol affect hair growth or skin texture? A guide covering systemic absorption, clinical evidence, and what patients with GSM can expect for hair and skin.
Low-dose testosterone has strong RCT support for hypoactive sexual desire disorder in postmenopausal women, yet no FDA-approved female formulation exists. The HealthRX.com Medical Team argues this gap is a regulatory failure, not a signal of unsafe or ineffective treatment.
Does hormone replacement therapy stop hair loss in women, or can it make thinning worse? This clinically reviewed guide covers the hormonal causes of hair loss, how estrogen and progesterone protect follicles, which HRT formulations help or harm, and what to expect in the first 6 to 12 months of treatment.
A board-reviewed deep look at whether topical estrogen creams, gels, and vaginal preparations flare rosacea, what the evidence says, and how to manage HRT safely if you have rosacea-prone skin.
Protein reduces cravings for low-nutrient foods by modulating hunger hormones, slowing gastric emptying, and increasing satiety signals. Learn the clinical mechanisms, optimal doses, and practical strategies backed by trial data.
Menopause accelerates collagen loss by up to 30% in the first five years. Learn which strategies, nutrients, peptides, and hormone therapies actually rebuild collagen production after 40, with clinical evidence.
A complete clinical guide for women on how to test for metabolic syndrome, covering diagnostic criteria, lab panels, waist measurement, and next steps after diagnosis.
Evidence-based review of testosterone therapy for low libido in women, including HSDD diagnosis, trial data from APHRODITE and ADORE, FDA-approved alternatives, and clinical dosing guidance.
A guide explaining how estrogen, progesterone, and testosterone-based HRT affect female libido, what the clinical evidence shows, and when FDA-approved or off-label treatments are appropriate.
An evidence-based analysis of who Gennev is best suited for, what it prescribes, how much it costs, and how it compares to alternatives for managing menopause symptoms.
A critical, evidence-based review of Alloy's LegitScript status, state medical board oversight, FDA compliance, BBB standing, and clinical legitimacy as a women's HRT telehealth provider.
A clinical guide comparing enclomiphene citrate and Jatenzo (oral testosterone undecanoate) for male hypogonadism, with decision frameworks for switching when one therapy stops working.
A clinical comparison of testosterone cypionate injections and AndroGel testosterone gel, with evidence-based guidance on recognizing failure and switching between formulations.
Black, Hispanic, and Asian women experience perimenopause differently from white women in symptom burden, duration, and access to care. Learn what the research shows and what clinical guidelines recommend.
A guide covering the pharmacological interaction between vaginal estradiol and metformin, including mechanism, safety, monitoring, and patient counseling.
A guide to testosterone cypionate dosing, mechanism of action, and clinical management when liver function is compromised. Includes trial data, FDA label guidance, and a practical dosing framework.
A deep dive into how testosterone cypionate affects sexual function in men with hypogonadism, including trial data, dosing considerations, and evidence boundaries.
An evidence-based guide to how testosterone enanthate affects bone mineral density, fracture risk, and skeletal health in men with hypogonadism, with primary-literature citations throughout.
How long to hold testosterone enanthate before surgery, why the pause matters for clotting and hemodynamic risk, and how to restart TRT safely post-op, a physician-level clinical reference.
An independent, critical review of Gennev's menopause telehealth platform. Learn which patient profiles are a poor fit, what complaints exist, and whether Gennev is legitimate.
A prescriber-level guide to recognizing, grading, and managing adverse events across all testosterone formulation classes, with dosing adjustments, monitoring intervals, and guideline-backed protocols.
A prescriber-level guide to testosterone formulation classes, ICD-10 coding, prior authorization strategy, and formulary navigation for male hypogonadism and related indications.
A comprehensive MD/PharmD-level review of testosterone formulation classes, their pharmacokinetics, and a complete drug-drug interaction table covering anticoagulants, insulin, corticosteroids, and more, with primary-source citations.
A comprehensive MD/PharmD-level guide to the testosterone formulations drug class, covering all delivery routes, laboratory monitoring protocols, dose titration, and safety surveillance for male hypogonadism management.
A prescriber-level review of testosterone formulation classes, with evidence-based titration and tapering algorithms, dosing tables, and guideline citations for male hypogonadism management.
A clinical comparison of AndroGel (testosterone gel) and Jatenzo (oral testosterone undecanoate) side-effect profiles, including cardiovascular risk, skin reactions, GI effects, and dosing practicality for men on TRT.
A clinical comparison of testosterone cypionate injections and AndroGel (testosterone gel), including how to switch safely between them, pharmacokinetics, dosing, and which form suits different patient profiles.
A head-to-head clinical breakdown of AndroGel (testosterone gel) versus Jatenzo (oral testosterone undecanoate) covering pharmacokinetics, efficacy data, cardiovascular signals, and practical switching guidance for men on TRT.
Learn how genetics and family history shape menopause timing, symptom severity, and treatment response. Evidence-based guidance from primary trials and society guidelines for women and their clinicians.
Menopause symptoms are frequently mistaken for thyroid disease, depression, anxiety, ADHD, and other conditions. Learn which diagnoses are most often missed, how to tell them apart, and what guidelines say about getting the right diagnosis and treatment.
A guide to recognizing menopause treatment failure, when to switch therapies, and how society guidelines define inadequate response to HRT and non-hormonal options.
A deep dive into the emerging mechanisms behind menopause, covering kisspeptin-neurokinin B-dynorphin signaling, neuroinflammation, mitochondrial biology, and what these findings mean for treatment decisions.
A comprehensive clinical history of perimenopause treatment from the 1960s through today, covering hormone therapy, the WHI trial fallout, and current evidence-based guidelines for managing symptoms.
Beyond hot flashes and irregular periods, perimenopause can present as new-onset seizures, auditory changes, autonomic dysfunction, and more. Learn the uncommon signs, their mechanisms, and evidence-based management.
A comprehensive, evidence-based guide to menopause treatment options in 2026, including hormone therapy, non-hormonal medications, lifestyle strategies, and how to choose the right approach for your symptoms and health history.
A guide to discontinuing Jatenzo (oral testosterone undecanoate) safely, covering tapering strategies, HPG axis recovery, symptom management, and when to restart therapy.
A guide to free testosterone reference ranges by sex, menstrual cycle phase, and age, with guidance on optimal levels for TRT and hormone therapy titration.
Learn how to interpret free testosterone rate-of-change, optimal ranges, and what rising or falling values mean for TRT dose titration and androgen health.
How to interpret a total testosterone trend rather than a single value: expected aging decline, measurement noise versus real change, TRT monitoring intervals, and when a falling trend warrants a workup.
A clinical deep-dive into how Jatenzo (oral testosterone undecanoate) affects libido, erectile function, mood, energy, and relationship quality, with real trial data, dosing context, and practical guidance for men and their partners.
An evidence-graded look at menopause nutrition, covering phytoestrogens, calcium, vitamin D, protein, dietary fat, and alcohol, with honest grading of trial quality and what remains unverified.
An evidence-bound comparison of anastrozole and exemestane during testosterone therapy, separating established mechanism and label facts from unproven male TRT superiority claims.
A complete clinical guide to clomiphene citrate (Clomid) for men with low testosterone, including how it works, dosing protocols, comparison to testosterone cypionate and enanthate, and who qualifies.
LegitScript certification
Verify HealthRX.comHealthRX.com is a platform connecting patients with independent licensed healthcare providers and pharmacies. Those providers deliver medical care and pharmacies dispense medication. Prescriptions are issued only when clinically appropriate. Payment does not guarantee a prescription.
Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality. Individual results vary.
Website information is educational and is not a substitute for personalized medical advice, diagnosis, or treatment. Consult your licensed healthcare provider.